News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
222,885 Results
Type
Article (4990)
Company Profile (17)
Press Release (217878)
Section
Business (82192)
Career Advice (461)
Deals (15040)
Drug Delivery (8)
Drug Development (19059)
Employer Resources (30)
FDA (3674)
Job Trends (3898)
News (120091)
Policy (7500)
Tag
Academia (290)
Alliances (14744)
Alzheimer's disease (227)
Approvals (3678)
Artificial intelligence (28)
Bankruptcy (95)
Best Places to Work (2855)
Breast cancer (39)
Cancer (338)
Career advice (391)
Cell therapy (77)
Clinical research (15859)
Collaboration (120)
Compensation (106)
COVID-19 (297)
C-suite (65)
Data (373)
Diabetes (29)
Diagnostics (2016)
Earnings (40104)
Employer resources (31)
Events (37287)
Executive appointments (219)
FDA (3844)
Funding (138)
Gene therapy (34)
GLP-1 (99)
Government (407)
Healthcare (5022)
Infectious disease (309)
Inflammatory bowel disease (23)
Interviews (53)
IPO (7781)
Job creations (1120)
Job search strategy (360)
Layoffs (97)
Legal (2327)
Lung cancer (35)
Manufacturing (38)
Medical device (3835)
Medtech (3836)
Mergers & acquisitions (7378)
Metabolic disorders (91)
Neuroscience (292)
NextGen: Class of 2025 (1672)
Non-profit (727)
Northern California (672)
Obesity (44)
Opinion (29)
People (24343)
Phase I (4733)
Phase II (6898)
Phase III (5467)
Pipeline (313)
Postmarket research (625)
Preclinical (1845)
Press Release (66)
Radiopharmaceuticals (104)
Rare diseases (55)
Real estate (1870)
Regulatory (5036)
Research institute (298)
Resumes & cover letters (68)
Southern California (503)
Startups (1007)
United States (5265)
Vaccines (27)
Date
Today (24)
Last 7 days (132)
Last 30 days (694)
Last 365 days (10846)
2025 (681)
2024 (11031)
2023 (13196)
2022 (18661)
2021 (19680)
2020 (18242)
2019 (13207)
2018 (10205)
2017 (10004)
2016 (9160)
2015 (12119)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (182)
Arizona (52)
Asia (11359)
Australia (1580)
California (1398)
Canada (555)
China (43)
Colorado (62)
Connecticut (72)
Europe (24167)
Florida (186)
Georgia (27)
Illinois (88)
Indiana (45)
Japan (44)
Kansas (24)
Maine (36)
Maryland (166)
Massachusetts (1157)
Michigan (75)
Minnesota (116)
New Jersey (414)
New York (368)
North Carolina (266)
Northern California (672)
Ohio (42)
Pennsylvania (267)
South America (274)
Southern California (503)
Texas (170)
Utah (41)
Virginia (29)
Washington State (122)
222,885 Results for "yuhan corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Ubix Therapeutics and Yuhan Announce Exclusive License Agreement for UBX-103, an Oral Small Molecule AR Degrader for Treatment of Metastatic Castration Resistant Prostate Cancer
Ubix Therapeutics, Inc., a biotechnology company discovering and developing innovative oncology therapeutics based on targeted protein degradation (TPD), announced today that it has entered into an exclusive license agreement with Yuhan to develop and commercialize preclinical androgen receptor (AR) degrader program, UBX-103.
July 1, 2024
·
2 min read
Yuhan Corporation and J INTS BIO inked a licensing agreement for a New Drug Candidate targeting HER2 NSCLC
Yuhan Corporation announced on the 30th of May that it has signed an in-license agreement with J INTS BIO for a Tyrosine Kinase Inhibitor targeting HER2, ‘JIN-A04'.
May 31, 2023
·
1 min read
Press Releases
Kelyniam Corporate Update
January 21, 2025
·
2 min read
Press Releases
Change to the Roche Enlarged Corporate Executive Committee
January 29, 2025
·
3 min read
Press Releases
Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach
January 14, 2025
·
4 min read
Press Releases
Optimi Health Provides Corporate Update
Non-Brokered Private Placement and Debt Settlement
January 17, 2025
·
5 min read
Press Releases
Britannia Life Sciences Inc. Provides Corporate Update
January 29, 2025
·
3 min read
Press Releases
Palatin Provides Update on Anticipated 2025 Corporate Milestones
January 28, 2025
·
6 min read
Press Releases
Arbutus Provides 2025 Corporate and Financial Update
January 14, 2025
·
11 min read
Press Releases
Aridis Provides Corporate Update
December 20, 2024
·
9 min read
1 of 22,289
Next
